The U.S. Food and Drug Administration has cleared Waltham, Mass.-based EarlySense’s EarlySense 2.0 bedside monitoring system, according to a news release by the company. The new bedside monitoring ...

A study, published in JAMA pediatrics, examined the factors that affect response time to physiologic monitor alarms among nurses in a hospital medical unit. Researchers investigated nurse response to ...

SEATTLE--(BUSINESS WIRE)--CalmWave, a solution aimed at reducing non-actionable alarms through a data science and artificial intelligence (AI) program, has successfully completed a proof-of-concept ...

Expanding the long-running partnership will bring Medtronic technologies, such as the Nellcor pulse oximetry product, to more ...

This month the FDA cleared the second generation of Waltham, Massachusetts-based EarlySense's passive and contactless bedside monitor, which continuous measures respiration rate, heart rate and motion ...

Keeping in line with Fukuda’s history of innovation, the company has announced a healthcare solution for patient monitoring to add to its’ impressive lineup ...

Fukuda introduced two innovative medical devices to its extensice product line to advance patient monitoring capabilities in the healthcare sector. The medtech industry is flourishing with new, more ...